EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild‐to‐Moderate Anxiety During the COVID‐19 Lockdown

Cristina Pages-García iD, M Cristina De Almagro iD, Jorge Ruiz-Moreno iD, Roser De Castellar iD

Depression and Anxiety · 2024-01 · 2024 (1)

DOI: 10.1155/2024/3661412 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Depression and Anxiety, online erschienen am 10.11.2024. Verfasst von Cristina Pages-García und 3 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, Hospital Universitario, Toledo, Hospitales de Madrid HM IMI Toledo, Unidad de Suelo Pélvico, Toledo, Spain. Hauptthemen laut MEDLINE: COVID-19, Dietary Supplements, Crocus, Anxiety. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A nutritional supplement based on medicinal plants (saffron and ashwagandha), tryptophan, and vitamin B6 could contribute to alleviating/improving mood and associated disorders. The aim of this study was to evaluate the potential benefits of this combination supplement. During the study period, participants underwent a period of forced home confinement due to the COVID‐19 pandemic, which represented an unexpected impact factor.

Methods

This open‐label prospective trial enrolled a cohort of female employees who reported mild to moderate anxiety. The primary objective was to evaluate changes in the level of anxiety using the adapted Hamilton Anxiety Rating Scale (HARS) after 12 weeks of regular supplementation with Safromotive (two tablets daily, for 12 weeks). The secondary objectives were to evaluate health‐related quality of life (HRQoL) and tolerability.

Results

In total, 46 women with a mean age of 45.0 (6.5) years were included. A statistically significant improvement in HARS was observed, with a 7.5‐unit decrease from baseline to 12 weeks ( p < 0.0001) and from 4 to 12 weeks of supplement intake ( p = 0.0058). However, no significant changes were found during the lockdown period (between weeks 8 and 12 of the study). No relationship was found between women’s sociodemographic characteristics and the HARS total score. A significant reduction in the HRQoL questionnaire score of 1.2 units was observed between baselines and 12 weeks of treatment ( p = 0.0273). At the end of the study, 78.6% of the women reported consistency the supplement intake during the study course.

Conclusion

This nutritional supplement composed of saffron, ashwagandha, tryptophan, and vitamin B6 appears to improve anxiety and HRQoL, but confinement could have impacted the evolution of the outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Dietary SupplementsCrocusAnxietyHumansFemaleMiddle AgedAdultProspective StudiesQuality of LifeTryptophanVitamin B 6QuarantineTreatment Outcome

Stichwörter der Autor:innen

Crocus sativusWithania somniferaanxietydepressionquarantine

Substanzen

TryptophanVitamin B 6

Autor:innen und Institutionen

  • Obstetrics and Gynecology Department, Hospital Universitario, Toledo, Hospitales de Madrid HM IMI Toledo, Unidad de Suelo Pélvico, Toledo, Spain.
  • Parc Científic de Barcelona, Laboratorios Ordesa S.L., Barcelona 08028, Spain.
  • Head of Biometry, Mixestat S.L., Barcelona 08021, Spain.
  • Clinical Research Unit, Medical Affairs Department, Laboratorios Ordesa S.L, Barcelona 08038, Spain.

ORCID-Profile: Cristina Pages-García, M Cristina De Almagro, Jorge Ruiz-Moreno, Roser De Castellar

Zitieren

APA

Pages-García, C., De Almagro, M. C., Ruiz-Moreno, J., & De Castellar, R. (2024). Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild‐to‐Moderate Anxiety During the COVID‐19 Lockdown. Depression and Anxiety, 2024(1). https://doi.org/10.1155/2024/3661412

Vancouver

Pages-García C, De Almagro MC, Ruiz-Moreno J, De Castellar R. Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild‐to‐Moderate Anxiety During the COVID‐19 Lockdown. Depression and Anxiety. 2024;2024(1). doi:10.1155/2024/3661412

BibTeX
@article{PagesGarca2024,
  author = {Pages-García, Cristina and De Almagro, M Cristina and Ruiz-Moreno, Jorge and De Castellar, Roser},
  title = {Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild‐to‐Moderate Anxiety During the COVID‐19 Lockdown},
  journal = {Depression and Anxiety},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/3661412}
}
Kostenlos starten →